0.03
0.03 (0%)
As of Apr 05, 2024
Gamida Cell Ltd. [GMDA]
Source:
Company Overview
Gamida Cell Ltd is a cell therapy pioneer working to turn cells into powerful therapeutics. We apply a proprietary expansion platform leveraging the properties of nicotinamide, or NAM, to allogeneic cell sources including umbilical cord blood-derived cells and natural killer, or NK, cells to create cell therapy candidates, with the potential to redefine standards of care.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | (617) 892-9080 |
| Industry | manufacturing |
| CEO | Abigail Jenkins |
| Website | www.gamida-cell.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.9 |
| Operating Profit | |
| Net Income | $19.9 |
| Net Cash | $-21.8 |
Profit Ratios
| Gross Margin | |
| Operating Margin | |
| Profit as % of Revenues | -2.9% |
| Profit as % of Assets | 22% |
| Profit as % of Stockholder Equity | -106.5% |
Management Effectiveness
| Return on Equity | -106.5% |
| Return on Assets | 25.1% |
| Turnover Ratio | 1% |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $79.6 |
| Total Liabilities | $98.3 |
| Operating Cash Flow | $-23 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $1.3 |
